• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Seroquel

A gavel in the foreground with the scale of justice in the background
Pharma

AstraZeneca escapes 1 of 2 Seroquel pay-for-delay claims

A federal judge said a $107 million value isn't sufficiently "large" or "justified" to sustain an antitrust claim for Seroquel XR.
Angus Liu Jul 8, 2022 11:58am
Human hands working with documents at desk and signing contrac

AZ sells U.S., Canada Seroquel rights to Cheplapharm for $42M

Dec 3, 2019 12:22pm
AstraZeneca

AstraZeneca's rummage sale continues with second deal in a week

Nov 6, 2018 10:08am
Legal and regulatory issues

AZ shells out $110M to wrap up Seroquel, Crestor marketing suits

Aug 8, 2018 10:35am
Asia Map

FiercePharmaAsia—Takeda-Shire, HKEX and more

May 11, 2018 9:55am
Handshake business deal executives

AstraZeneca revives yard-sale strategy with Seroquel rights sale

May 8, 2018 12:29pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings